Signaling Pathways
-
B3553 GS-9973Target: SykSummary: Syk inhibitor, orally bioavailable and selective
-
B4761 GNE-9605Summary: LRRK2 inhibitor, brain-penetrant, potent and selective
-
A8889 G-749Target: Aurora Kinases|FLT3|c-RETSummary: FLT3 inhibitor
-
A8881 WZ3146Summary: Mutant EGFR inhibitor, potent and irreversible
-
B8003 WH-4-023Summary: Lck/Src inhibitor,potent and selective
-
B8016 UNC20251 CitationTarget: MER|FLT3Summary: orally bioavailable dual MER/FLT3 inhibitor
-
B4882 PF-06463922Target: ALK|ROS1Summary: ALK/ROS1 inhibitor,potent and selective
-
B4800 DefactinibTarget: FAKSummary: FAK phosphorylation inhibitor
-
B4842 LDN-214117Summary: potent and selective ALK2 inhibitor
-
A8696 FIIN-2Target: FGFRSummary: Irreversible inhibitor of FGFR